HER inhibitors are compounds that block the activity of Human Epidermal Growth Factor Receptors, particularly HER2, which is overexpressed in certain breast cancers and other malignancies. Inhibition of HER signaling pathways is a key strategy in targeted cancer therapies. At CymitQuimica, we offer HER inhibitors to support your research in oncology, targeted therapies, and cell signaling.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.